Evidence map›Paper›PMID 36330520›Full record

ArticleFrontiers in immunology2022

T-cell receptor signaling in Schimke immuno-osseous dysplasia is SMARCAL1-independent.

Ana V Marin, Anaïs Jiménez-Reinoso, Marina S Mazariegos, Elena Román-Ortiz, José R Regueiro

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ana V MarinDepartment of Immunology, Ophthalmology and Ear, Nose and Throat (ENT), Complutense University School of Medicine and 12 de Octubre Health Research Institute (imas12), Madrid, Spain.
Anaïs Jiménez-ReinosoDepartment of Immunology, Ophthalmology and Ear, Nose and Throat (ENT), Complutense University School of Medicine and 12 de Octubre Health Research Institute (imas12), Madrid, Spain.
Marina S MazariegosDepartment of Immunology, Ophthalmology and Ear, Nose and Throat (ENT), Complutense University School of Medicine and 12 de Octubre Health Research Institute (imas12), Madrid, Spain.
Elena Román-OrtizPediatric Nephrology, Hospital Universitari i Politècnic la Fe, Valencia, Spain.
José R RegueiroDepartment of Immunology, Ophthalmology and Ear, Nose and Throat (ENT), Complutense University School of Medicine and 12 de Octubre Health Research Institute (imas12), Madrid, Spain.
Research Institute Hospital 12 de Octubre · ESHospital Universitari i Politècnic La Fe · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schimke immuno-osseous dysplasia (SIOD) caused by mutations in

Indexed as

Immunologic Deficiency SyndromesNephrotic SyndromeArteriosclerosisChildDNA HelicasesHumansOsteochondrodysplasiasPrimary Immunodeficiency DiseasesPulmonary EmbolismReceptors, Antigen, T-CellSignal TransductionDNA HelicasesReceptors, Antigen, T-CellSMARCAL1 protein, humanimmunosuppressionkidney failurelymphopeniaSchimkeSIODSMARCAL1T-cell

Identifiers

PMID36330520
PMCPMC9623027
OpenAlexW4306672613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.